newsfilter
← Latest News
Business Wire·

Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits

Regulatory milestone for specimen collection kits enables global deployment of Personalis' ultrasensitive MRD detection (Next Personal®) for drug development programs Personalis, Inc. (NASDAQ:PSNL), a leader in